A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...
Stocktwits on MSN
Ardelyx stock rises premarket as Piper sees over 100% upside — says constipation drug 'stole the show' with 2026 guidance
Piper upgraded Ardelyx to ‘Overweight’ and lifted its price target to $16 after sharply higher 2026 guidance. ・The company ...
Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting: Our Bureau, Bengaluru Friday, January 9, 2026, 12:15 Hrs [IST] Shilp ...
Agreement expands Madrigal’s pipeline and strengthens its leadership in pioneering MASH therapiesDGAT-2 inhibition represents a complementary ...
Agreement expands Madrigal's pipeline and strengthens its leadership in pioneering MASH therapiesDGAT-2 inhibition represents a complementary mechanism of action with Rezdiffra- (resmetirom) for poten ...
Indian Drinks & Cocktails You Need To Try at Least Once When you're travelling through India, the two things you'll ...
Drinking greens powder daily may help reduce bloating for some people, but others may experience gas or mild bloating during the first few days of use.
Bored Panda on MSN
52 vintage products that didn’t quite stand the test of time
"Catch your man with taste-tempting donuts!" That was an actual ad from the '50s or '60s urging women to trap men with baked ...
While the effect of VASCEPA on the risk of pancreatitis in patients with sHTG has not been determined, data from the Company’s pivotal MARINE study in patients with TGs between 500 and 2,000 mg/dL, ...
Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported preliminary, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results